April W. Armstrong, MD, MPH - Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care

Prof. Nicolas Girard, MD, PhD / Pasi A. Jänne, MD, PhD - Making Precision Decisions for Patients With EGFRm NSCLC: Success Strategies With Targeted Options, Potent Combinations, and Emerging Agents

Michelle Kittleson, MD, PhD - Implementing Targeted Therapies in Transthyretin Cardiac Amyloidosis: From Diagnosis to Stabilization

Stuart C. Gordon, MD, FACP, FACG, AGAF, FAASLD - Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management

Arun J. Sanyal, MBBS, MD - Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health

Prof. Sanjay Popat, FRCP, PhD - The Earlier the Better in Lung Cancer: Multispecialty Guidance on Screening, Diagnosis and Management of Resectable NSCLC

Milind Desai, MD, MBA / Anjali Tiku Owens, MD - Fine-Tuning Hypertrophic Cardiomyopathy Care in the CMI Era: Redefining Management for the Modern Heart Failure Specialist

Aleena Banerji, MD - Improving the Care of Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis

Alexis Ogdie, MD, MSCE, Robert H. Eckel, MD, FAHA, FACC - Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health

Paolo Ghia, MD, PhD - The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations

Peter A. Campochiaro, MD - Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care

Michelle C. Kaku, MD / Chafic Karam, MD - Targeted Therapy for Hereditary Transthyretin Amyloidosis Polyneuropathy (ATTRv-PN): You Don’t Want to Miss It!

Sandeep K. Gupta, MD, AGAF, FACG, FASGE, Jenifer R. Lightdale, MD, MPH - Fast Track to Relief: Accelerating Treatment Initiation and Supporting Patient Follow-Up in Pediatric Eosinophilic Esophagitis

Jared R. Brosch, MD - Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer’s Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management

Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC

Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC

M. Camille Hoffman, MD, MSc - From Screening Through Treatment: Proactive Engagement of Patients in Team-Based Care for PPD

Nitin Jain, MD - Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation

Kent E. Vrana, PhD, FAAAS, FASPET - Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making

Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities